Clinical trials: Neuroprotective Drugs
Brain Damage, Chronic
Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants
NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage.
- Trial name
- NEOBRAIN (NCT00544895)
- Where
- 12 sites in Austria, France and 5 more
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Hannover Medical School